Literature DB >> 10386570

Assessing the performance of utility techniques in the absence of a gold standard.

R B Giesler1, C M Ashton, B Brody, M M Byrne, K Cook, J M Geraci, M Hanita, J Souchek, N P Wray.   

Abstract

BACKGROUND: Utility techniques are the most commonly used means to assess patient preferences for health outcomes. However, whether utility techniques produce valid measures of preference has been difficult to determine in the absence of a gold standard.
OBJECTIVE: To introduce and demonstrate two methods that can be used to evaluate how well utility techniques measure patients' preferences. SUBJECTS AND
DESIGN: Patients treated for advanced prostate cancer (n = 57) first ranked eight health states in order of preference. Four utility techniques were then used to elicit patients' utilities for each health state. MEASURES: The rating scale, standard gamble, time trade-off, and a modified version of willingness-to-pay techniques were used to elicit patients' utilities. Technique performance was assessed by computing a differentiation and inconsistency score for each technique.
RESULTS: Differentiation scores indicated the rating scale permitted respondents to assign unique utility values to about 70% of the health states that should have received unique values. When the other techniques were used, about 40% or less of the health states that should have received unique utility scores actually did receive unique utility scores. Inconsistency scores, which indicate how often participants assign utility scores that contradict how they value health states, indicated that the willingness-to-pay technique produced the lowest rate of inconsistency (10%). However, this technique did not differ significantly from the rating scale or standard gamble on this dimension.
CONCLUSIONS: Differentiation and inconsistency offer a means to evaluate the performance of utility techniques, thereby allowing investigators to determine the extent to which utilities they have elicited for a given decision problem are valid. In the current investigation, the differentiation and inconsistency methods indicated that all four techniques performed at sub-optimal levels, though the rating scale out-performed the standard gamble, time trade-off, and willingness-to-pay techniques.

Entities:  

Mesh:

Year:  1999        PMID: 10386570     DOI: 10.1097/00005650-199906000-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  8 in total

Review 1.  Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data.

Authors:  Meenakshi Bewtra; F Reed Johnson
Journal:  Patient       Date:  2013       Impact factor: 3.883

2.  Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.

Authors:  Joseph D Shirk; Catherine M Crespi; Josemanuel D Saucedo; Sylvia Lambrechts; Ely Dahan; Robert Kaplan; Christopher Saigal
Journal:  Patient       Date:  2017-12       Impact factor: 3.883

3.  Psychological benefits of prostate cancer screening: the role of reassurance.

Authors:  Scott B Cantor; Robert J Volk; Alvah R Cass; Jawaria Gilani; Stephen J Spann
Journal:  Health Expect       Date:  2002-06       Impact factor: 3.377

4.  The reliability and internal consistency of an Internet-capable computer program for measuring utilities.

Authors:  L A Lenert
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

5.  Measuring preferences for schizophrenia outcomes with the time tradeoff method.

Authors:  Martha Shumway; Tandy L Chouljian; Cynthia L Battle
Journal:  J Behav Health Serv Res       Date:  2005 Jan-Mar       Impact factor: 1.505

Review 6.  The impact of economic evaluation on quality management in spine surgery.

Authors:  Norbert Boos
Journal:  Eur Spine J       Date:  2009-04-01       Impact factor: 3.134

7.  Estimation of utility weights for major liver diseases according to disease severity in Korea.

Authors:  Minsu Ock; So Yun Lim; Hyeon-Jeong Lee; Seon-Ha Kim; Min-Woo Jo
Journal:  BMC Gastroenterol       Date:  2017-09-05       Impact factor: 3.067

8.  Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.

Authors:  J Bernhard; D Zahrieh; A S Coates; R D Gelber; M Castiglione-Gertsch; E Murray; J F Forbes; L Perey; J Collins; R Snyder; C-M Rudenstam; D Crivellari; A Veronesi; B Thürlimann; M F Fey; K N Price; A Goldhirsch; C Hürny
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.